Company: AEMD
Filing Date: 2025-04-08
Form Type: PRE 14A
Source: 0001683168-25-002332
Chunk: 19

Company: AETHLON MEDICAL INC
Filing Date: 2025-04-08
Form: PRE 14A
Chunk 19
---
 Nasdaq Capital Market and does not affect the Company’s reporting requirements with the Securities and Exchange Commission. There can be no assurance, however, that we will be able to regain compliance with the Minimum Bid Price Requirement. Even if we do regain compliance, we may not be able to maintain compliance with the continued listing requirements for the Nasdaq Capital Market or our common stock could be delisted in the future. In addition, we may be unable to meet other applicable listing requirements of the Nasdaq Capital Market, including maintaining minimum levels of stockholders’ equity or market values of our common stock in which case, our common stock could be delisted notwithstanding our ability to demonstrate compliance with the Minimum Bid Price Requirement.

If we do not regain compliance with the Minimum Bid
Price Requirement, our common stock will be subject to delisting. The Board of Directors has considered the potential harm to us and our
stockholders should Nasdaq delist our common stock from The Nasdaq Capital Market. The delisting of our common stock by Nasdaq could adversely
affect the liquidity of our common stock, create increased volatility in our common stock, and result in a loss of current or future coverage
by certain sell-side analysts and/or a diminution of institutional investor interest. Delisting could also cause a loss of confidence
of our collaborators, vendors and employees, which could harm our business and future prospects. If our common stock is delisted by Nasdaq,
our common stock may be eligible to trade on the OTC Bulletin Board, OTC-QB or another over-the-counter market, which alternatives are
generally considered to be less efficient markets. Any such alternative would likely result in it being more difficult for us to raise
additional capital through the public or private sale of equity securities and for investors to dispose of or obtain accurate quotations
as to the market value of our common stock. Moreover, if our common stock is delisted, it may come within the definition of “penny
stock” under the Exchange Act, which imposes additional sales practice requirements on broker-dealers who sell securities to persons
other than established customers and accredited investors. These requirements may reduce trading activity in the secondary market for
our common stock and may impact the ability or willingness of broker-dealers to sell our securities which could limit the ability of stockholders
to sell their securities in the public market and limit our ability to attract and retain qualified employees or raise additional capital
in the future.

| 10 |

The Board of Directors believes that the proposed
Reverse Stock Split is